Fuji Pharma
A pharmaceutical company mainly engaged in the manufacture and sale of prescription based pharmaceutical products.
Launch date
Employees
Market cap
€210m
Enterprise valuation
€392m (Public information from Sep 2024)
Share price
JPY1273 4554.T
Tokyo Japan (HQ)
Financials
Estimates*
JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 33.8b | 34.0b | 35.4b | 40.9b | 46.2b | 50.8b | 55.9b |
% growth | - | 1 % | 4 % | 15 % | 13 % | 10 % | 10 % |
EBITDA | 5.1b | 5.4b | 6.8b | 7.3b | 7.2b | 8.4b | 9.0b |
% EBITDA margin | 15 % | 16 % | 19 % | 18 % | 16 % | 17 % | 16 % |
Profit | 2.1b | 2.4b | 2.7b | 3.4b | 5.8b | 3.9b | 4.2b |
% profit margin | 6 % | 7 % | 8 % | 8 % | 13 % | 8 % | 8 % |
EV / revenue | 1.1x | 1.1x | 1.3x | 1.3x | 1.3x | 1.1x | 1.0x |
EV / EBITDA | 7.4x | 6.8x | 6.8x | 7.5x | 8.1x | 6.9x | 6.3x |
R&D budget | 3.1b | 2.4b | 2.5b | 3.2b | - | - | - |
R&D % of revenue | 9 % | 7 % | 7 % | 8 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
Total Funding | - |
Related Content
Recent News about Fuji Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.